logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
06/06/2026
Market news: The US State Department has approved a potential deal to sell missiles to Denmark for $842 million.
Latest
2 m ago
NVIDIA plans to reduce the memory of AI chips? Huang Renxun: Use wisely and cleverly, strive for more supply.
10 m ago
Associated Press predicts that Democratic candidate Besler is leading in the California gubernatorial election.
15 m ago
An explosion at a coal mine in Colombia has killed seven people.
22 m ago
Middle Finger Research Institute: In May, residential rent in 50 cities continued to decline month-on-month, with a decrease approaching the lowest level in nearly three years.
32 m ago
Novo Nordisk: Subjects treated with Zenaglutide, when receiving the highest test dose of 40 mg at week 36, experienced a maximum weight loss of 14.6%. The study showed that compared to placebo, the drug can reduce blood sugar in adults with type 2 diabetes, with up to 89.1% of subjects achieving target levels of glycosylated hemoglobin.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.